1. Home
  2. CVGI vs COYA Comparison

CVGI vs COYA Comparison

Compare CVGI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

SELL

Current Price

$3.07

Market Cap

116.6M

ML Signal

SELL

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

SELL

Current Price

$2.95

Market Cap

102.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CVGI
COYA
Founded
2000
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.6M
102.7M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
CVGI
COYA
Price
$3.07
$2.95
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$7.50
★ $15.21
AVG Volume (30 Days)
★ 316.0K
157.7K
Earning Date
11-02-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 316.18
N/A
EPS
★ 0.04
N/A
Revenue
★ $755,231,000.00
$7,945,753.00
Revenue This Year
$17.64
N/A
Revenue Next Year
$6.23
$203.64
P/E Ratio
$83.38
★ N/A
Revenue Growth
14.06
★ 123.57
52 Week Low
$1.41
$2.72
52 Week High
$5.88
$6.62

Technical Indicators

Market Signals
Indicator
CVGI
COYA
Relative Strength Index (RSI) 47.28 32.97
Support Level $2.97 $2.72
Resistance Level $3.21 $5.15
Average True Range (ATR) 0.27 0.30
MACD -0.01 0.02
Stochastic Oscillator 11.49 33.33

Price Performance

Historical Comparison
CVGI
COYA

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: